Clonidine Transdermal Patch and Tranylcypromine: Interaction Details

Brand names
Tranylcypromine
Parnate
Clonidine Transdermal Patch
Catapres-TTSKapvayNexiclon +8 more
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Clonidine Transdermal Patch and Tranylcypromine interaction:

Share

Share this interaction

Clonidine Transdermal Patch

Brand names
  • Catapres-TTS
  • Kapvay
  • Nexiclon
  • Onyda
  • Javadin
  • Qlonilik
  • Duraclon
  • Catapres
  • Catapres-TTS-1
  • Catapres-TTS-2
  • Catapres-TTS-3

What Happens When You Take Clonidine Transdermal Patch With Tranylcypromine

What can happen when they are taken together (rated Contraindicated)

Increased risk of hypertensive reaction, including intracerebral

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Because of a heightened risk of an hypertensive reaction, which includes the possibility of intracerebral hemorrhage, tranylcypromine (a , or ) is when given together with a sympathomimetic agent or in close succession to one. Should an emergency arise in which no therapeutic alternatives exist and a contraindicated drug, for example a direct-acting sympathomimetic, must be used, tranylcypromine should be stopped as soon as possible before the sympathomimetic agent is begun, with close monitoring for adverse effects throughout its use.

When tranylcypromine is to be started in a patient already taking a contraindicated drug, that drug should first be discontinued, and initiation of tranylcypromine should be delayed for at least 4 to 5 half-lives of the contraindicated drug or its active .67 Once tranylcypromine is stopped, interactions remain possible until MAO activity has adequately recovered, as MAO can last for as long as 10 days after discontinuation.6

The Clonidine Transdermal Patch and Tranylcypromine Interaction, Explained

Tranylcypromine (Parnate) is an antidepressant called an . It changes how your body handles natural chemicals that can raise blood pressure. The clonidine patch (Catapres-TTS) is usually used to lower blood pressure, but it acts on some of the same body signals. Experts list this pair as one to avoid because, in theory, it could set off a dangerous spike in blood pressure, which in rare cases can cause bleeding in the brain. This is based on how the drugs work, not on many reported cases.

Please don't stop either medicine or take off your patch on your own. Talk with your pharmacist or doctor. They can review your plan and keep you safe.

Tranylcypromine + clonidine transdermal: (theoretical evidence). Labeling contraindicates tranylcypromine (irreversible nonselective ) with sympathomimetic agents, including clonidine, a centrally acting alpha-2 , because of an hypertensive reaction with risk of intracerebral . The precise mechanism is unknown. Onset is unspecified, and the magnitude is not quantified.

  • Avoid or use in rapid succession. Select a therapeutic alternative.
  • If clonidine is required emergently with no alternative, discontinue tranylcypromine as soon as possible beforehand and monitor BP and adverse effects closely.
  • Before starting tranylcypromine, discontinue clonidine (tapered, given rebound hypertension risk) and wait at least 4 to 5 half-lives of the drug or its active .
  • MAO may persist up to 10 days after tranylcypromine is stopped.

See the 9 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Clonidine Transdermal Patch and Tranylcypromine Interact

The likely mechanism

Unknown

“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.

When two medicines can each cause the same effect, here bleeding, taking them together can add to it. That is often the reason for an interaction like this one, though the sources do not confirm it for this pair.

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Clonidine Transdermal Patch and Tranylcypromine Interaction

This combination is generally not used together. Here is what your care team typically does:

  • Chooses a different medicine in place of one of these two.
  • Leaves a waiting period when switching between them. The effects of tranylcypromine can last up to 10 days after the last dose.
  • Watches you closely if both are truly needed in an emergency.

What you can do: Keep using your medicines as prescribed until you talk with your care team, and don't remove your patch or skip doses on your own. Make sure your pharmacist and every prescriber know you take both.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Clonidine Transdermal Patch or Tranylcypromine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

4 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Monoamine oxidase inhibitors

    The literature well documents an association between ePHEDrine and tranylcypromine and the occurrence of severe headaches and hypertensive crises. Additional possible reactions include cardiac , chest pain, hyperpyrexia, and death.1

  2. Report 2 · Study title

    Increased blood pressure responses to dopamine and norepinephrine produced by monoamine oxidase inhibitors in man

    Because DOPamine undergoes by MAO, its effects will be prolonged in patients taking . This interaction may lead to severe hypertension and/or cardiac . Patients receiving MAO inhibitors should be given no more than one-tenth of the usual DOPamine dose.8

  3. Report 3 · Study title

    Computerized drug interaction programs: how reliable (letter)?

    A 40-year-old woman taking the phenelzine for chronic depression started Midrin® (isometheptene, dichloralphenazone, and acetaminophen) for headaches. Within 40 minutes after her first Midrin® dose, she developed diaphoresis, neck pain, worsening headache pain, palpitations, nonsustained ventricular , and premature ventricular contractions.

    In the ER, she received treatment for , including IV phentolamine, which rapidly resolved her symptoms. About 6 hours later, the symptoms returned.

    Upon reexamination, she had a small elevation of creatine phosphokinase enzyme with positive MB fractions. She had no history of, or risk factors for, coronary artery disease, and her showed no ST-segment or T-wave abnormalities. Subsequent echocardiogram and treadmill testing were normal.9

  4. Report 4 · Study title

    Hypertensive crisis due to pargyline and metaraminol

    Isoproterenol, a direct-acting catecholamine sympathomimetic, may interact with a concurrently administered , producing clinically significant hypertensive effects.4235

Clonidine Transdermal Patch and Tranylcypromine: Common Questions

How serious is the Clonidine Transdermal Patch and Tranylcypromine interaction?

It is rated . These should generally not be used together.

How is the Clonidine Transdermal Patch and Tranylcypromine interaction managed?

This combination is generally not used together. Here is what your care team typically does: Chooses a different medicine in place of one of these two. Leaves a waiting period when switching between them. The effects of tranylcypromine can last up to 10 days after the last dose. Watches you closely if both are truly needed in an emergency. What you can do: Keep using your medicines as prescribed u… Management is individual — always follow your own care team's guidance.

Is there an alternative to taking Clonidine Transdermal Patch with Tranylcypromine?

Here is what your care team typically does: Chooses a different medicine in place of one of these two.

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Clonidine Transdermal Patch and Tranylcypromine Interaction

Ask in your own words about taking Clonidine Transdermal Patch and Tranylcypromine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (9)

  1. Goldberg LI: Monoamine oxidase inhibitors. Adverse reactions and possible mechanisms. JAMA 1964; 190:456-462. DOI
  2. Smookler S & Bermudez AJ: Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant. Ann Emerg Med 1982; 11:482-484. PubMed
  3. Cuthbert MF, Greenberg MP, & Morley SW: Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors. Br Med J 1969; 1:404-406. DOI
  4. Horler AR & Wynne NA: Hypertensive crisis due to pargyline and metaraminol. Br Med J 1965; 2:460-461. PubMed
  5. Boakes AJ, Laurence DR, Teoh PC, et al: Interactions between sympathomimetic amines and antidepressant agents in man. Br Med J 1973; 1:311-315. DOI
  6. Product Information: Tranylcypromine oral tablets, tranylcypromine oral tablets. Solco Healthcare US, LLC (per DailyMed), Somerset, NJ, 2024. DailyMed
  7. Product Information: PARNATE(R) oral tablets, tranylcypromine oral tablets. Concordia Pharmaceuticals, Inc. (per FDA), Kansas City, MO, 2018. DailyMed
  8. Horwitz D, Goldberg LI, & Sjoerdsma A: Increased blood pressure responses to dopamine and norepinephrine produced by monoamine oxidase inhibitors in man. J Lab Clin Med 1960; 56:747.
  9. Kraft KE & Dore FH: Computerized drug interaction programs: how reliable (letter)?. JAMA 1996; 275:1087. DOI
Was this write-up helpful?

Other Serious Interactions of Clonidine Transdermal Patch and Tranylcypromine

Also serious with Tranylcypromine

Also serious with Clonidine Transdermal Patch

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Tranylcypromine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.